Published online Jun 30, 2019. doi: 10.13105/wjma.v7.i6.269
Peer-review started: March 20, 2019
First decision: May 16, 2019
Revised: June 7, 2019
Accepted: June 16, 2019
Article in press: June 17, 2019
Published online: June 30, 2019
Multivisceral resections (MVR) still constitute a challenge for the interdisciplinary team. The indications to perform MVR are not clearly defined.
Motivation was generated by the fact that there are no recommendations regarding MVR.
In order to define indications and factors associated with beneficial oncologic outcomes and reduced perioperative morbidity and mortality this systematic review was conducted.
We performed a PubMed-search from 2000 to 2018 including articles reporting on MVR in pa-tients with colon-, rectal- and gastric cancer.
Available data shows that MVR from locally advanced colorectal and gastric cancer is a feasible option which is associated with acceptable morbidity- and mortality-rates. Oncologic outcome is favorable when clear resection margins can be obtained.
Patients who are clinically fit and preoperative imaging does not reveal obvious contraindication for radical surgery, the option of MVR should not be abandoned. Clear resection margins are the main goal of aggressive surgical approach.
Perspectives are to evaluate more patient- and treatmenspecific parameters in order to define more clearly patients who are likely to benefit from this approach.